Study Comparing Bevacizumab + Temsirolimus Vs Bevacizumab + Interferon-Alfa In Advanced Renal Cell Carcinoma Subjects

Sponsor and Collaborators
Wyeth

Contact
Trial Manager
clintrialparticipation@wyeth.com
50 Study Locations

Principal Investigator
Study Director: Medical Monitor
Wyeth

Clinical Trials.gov Identifier

NCT00631371


Continue Reading